Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Sep 10, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reminder: NIH Natural Disaster Policy Hurricanes Henri and Ida
National Institutes of Health
General Notices
- NHLBI Announces Interest in Promoting Cardiovascular and Cardiometabolic Health in Early Stages of the Lifecourse: Pre-adolescence Through Adolescence to Young Adulthood
National Heart, Lung, and Blood Institute
- The BRAIN Initiative Plan for Enhancing Diverse Perspectives (PEDP)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Notice of Change to the Award Information in PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
National Institute for Occupational Safety and Health
- Notice of Change to Award Information for PAR-21-165
National Institute for Occupational Safety and Health
- Receipt Date Added for Commercial Fishing Occupational Safety Training Project Grants (T03)
National Institute for Occupational Safety and Health
- Receipt Date Added for Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
National Institute for Occupational Safety and Health
- Request for Information (RFI) on User Experience with Scientific Data Sources and Tools
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice to Extend the Expiration Date of PAR-18-877 "Early Stage Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)"
National Institute on Aging
- Notice to Extend the Expiration Date of PAR-18-878 "Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)"
National Institute on Aging
- Notice of Participation of the National Institute on Aging (NIA) in RFA-NS-21-014 "BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)"
National Institute on Aging
- Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in RFA-DA-22-031, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in RFA-DA-22-032, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Notice of Change to the Expiration Date and the Last Receipt Date of PAR-19-287, "Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)"
National Cancer Institute
- Notice of Change to NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications"
National Institute of Biomedical Imaging and Bioengineering
- Notice of NHLBI Addition to PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
National Heart, Lung, and Blood Institute
- Notice of Correction to Expiration Date for NOT-HL-21-024 Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases (Reissue)
National Heart, Lung, and Blood Institute
- Notice to Extend PA-16-453 " AHRQ Conference Grant Programs (R13)"
Agency for Healthcare Research and Quality
- Notice of Change to PAR-22-026 "Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42, R43/R44 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Notice of Special Interest (NOSI): Promoting Cardiovascular and Cardiometabolic Health in Early Stages of the Lifecourse: Pre-adolescence Through Adolescence to Young Adulthood
National Heart, Lung, and Blood Institute
Funding Opportunities
- NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
- NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
National Cancer Institute
- Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
- Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institute of Dental and Craniofacial Research
- NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
National Institute on Drug Abuse
- Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
- Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)
National Cancer Institute
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
National Cancer Institute
- NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
National Institute on Drug Abuse
- Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
- National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
National Cancer Institute
- Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)
- Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)
National Cancer Institute
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed)
National Cancer Institute
- Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not Allowed
- Limited Competition: Knockout Mouse Phenotyping Project Data Coordination Center and Database (UM1 Clinical Trial Not Allowed)
National Human Genome Research Institute
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Research on Women's Health
- HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Dental and Craniofacial Research
- World Trade Center Health Research-Related to WTC Survivors (U01 no Applications with Responders Accepted)
National Institute for Occupational Safety and Health
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.